ACE2 and acute respiratory distress syndrome: However, in the COVID-19 patients that developed acute respiratory distress syndrome (ARDS) and required a ventilator, ACE2 was expressed in CD14 monocytes, CD8 effector T cells, dendritic cells, stem cells, and eosinophils (Figure 4d).